No profile data available.
Rapid Micro Biosystems, Inc. (RPID) is a healthcare company in the biological analysis equipment industry, based in Lexington, United States, with about 171 full-time employees.
It reported revenue of $33.59 million for fiscal year 2025, up 19.7% from fiscal year 2024, and net income of -$47.12 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $8.05 million, up 10.9% from a year before. United States was its largest region in fiscal year 2025, with 40% of revenue. Its market capitalization was $43.22 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.
Rapid Micro Biosystems reported $33.59 million in revenue for fiscal year 2025, up 19.7% from $28.05 million in fiscal year 2024. In Q2 2026 revenue was $8.05 million.
United States: 40% of revenue by region in fiscal year 2025, followed by Switzerland (18%).
$43.22 million as of October 8, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include MaxCyte, Inc. (MXCT), Seer, Inc. (SEER), INmune Bio, Inc. (INMB), Bionano Genomics, Inc. (BNGO).